Search results for "virus" in Articles / App Notes
								 					Article
				
				Successful Wetting for Filter Integrity Testing in Volume-Restricted Systems
								
	 
	
In a validated GMP process, filters must be routinely tested for integrity. The automated test instruments that are used for filter integrity testing have been improved over the past 40 years. …								
								 					Article
				
				How to develop a scalable rAAV process
								
	
	
	Adeno-associated virus (AAV) is the most common vector for gene therapy, yet there’s much room to improve production, purification, and analytics. Here we present the latest updates to our wor…								
								 					Article
				
				What is process development?
								And ultracentrifugation to separate empty from full capsids of adeno-associated virus (AAV) does not scale well. Consider scalability from the start to avoid the need to rework your process.
	
	
		And…								
								 					Article
				
				From cells to purified capsids: How to develop a scalable rAAV process
								
	
	
	
	Adeno-associated virus (AAV) is the most common vector for gene therapy, yet there’s much room to improve production, purification, and analytics. In this webinar we present the latest upd…								
								 					Article
				
				How to optimize AAV capsid separation
								 
	In this free, interactive course you’ll learn how to tackle one of the key challenges in Adeno-associated virus (AAV) manufacturing–separating full and empty capsids in the polishing step. You’ll …								
								 					Article
				
				Cell culture process development for AAV vector production in suspension cells
								
	
	
	  
	
	
	  
	Adaptation of HEK293 suspension cell line for transient transfection and scalable adeno-associated virus (AAV) production. 
	
	
  
	READ FULL ARTICLE >> 
								
								 					Article
				
				Top Process Development Trends for 2021 and a Look into 2022
								However, the focus in 2021 shifted beyond the pandemic to optimization and scaling up adeno-associated virus (AAV) production, process workflows and considerations for messenger RNA (mRNA) therapeutic…								
								 					Article
				
				Pandemic Alters Policies and Practices for Drug Development and Regulation
								The desperate need for new vaccines and therapies to tame the deadly COVID-19 virus required new policies and procedures for how biopharma companies select, test, and manufacture medical products—and …								
								 					Article
				
				Scalable AAV Production Process for Gene Therapy
								Several viruses have been investigated for use in cell and gene therapy; adeno-associated virus (AAV) has emerged as the main vector for gene therapies. Here, we describe how we developed an efficient…								
								 					Article
				
				Insights and Strategies for Successful Development of Scalable AAV Processes: Part 2 of 2
								
	part2 
	
		Click here to view more Industry Leader Q&As >> 
		
	
	
		In the second of a two-part series, Anki Magnusson, Staff Research Engineer, Protein and Viral Production, and Åsa Hagner…